ABEC Enhances Bioprocess Optimization with Expanded Process Sciences Group

ABEC Expands Process Sciences Group to Enhance Bioprocess Optimization Capabilities

BETHLEHEM, Pa., May 6, 2026 – ABEC, renowned as a leader in bioprocess engineering solutions, is embarking on an exciting new journey with the expansion of its Process Sciences group. This initiative is designed to enhance the company’s capabilities to assist biopharmaceutical manufacturers in expediting development processes, mitigating risks, and improving productivity throughout the bioprocess lifecycle.

The expanded Process Sciences team synergistically merges expertise in chemical and bioengineering with progressive techniques such as advanced modeling and experimental testing. Their primary aim is to bolster customer support from the initial stages of development through to commercial production.

At the heart of ABEC's Process Sciences philosophy lies a profound understanding of bioprocessing. Engineers meticulously analyze and optimize critical parameters like mass transfer, agitation, blend time, shear, and CO₂ stripping to accomplish specific objectives while avoiding common pitfalls in mixing and scaling processes. This portfolio of expertise spans microbial fermentation and animal cell culture processes, allowing ABEC to provide tailored solutions across an extensive spectrum of biomanufacturing applications.

ABEC stands out by offering dedicated facilities that further empower process validation through live cell or microbial runs across varied scales from 200mL to 6,000 liters, complemented by Computational Fluid Dynamics (CFD) and other modeling tools. These efforts yield crucial data supporting Quality by Design initiatives and effective process characterization.

The use of advanced CFD simulations significantly curtails the time and expenditures associated with development. By lessening the dependency on experimental runs, ABEC effectively diminishes risks linked to scale-up and technology transfer decisions. Instead of conforming processes to existing standard equipment, the company opts for designing systems that precisely meet defined process requirements, ensuring optimized performance that adheres to client specifications.

Scott Pickering, a representative from ABEC, articulated the company's commitment: "Process Sciences grants our customers the confidence needed as they transition from development to large-scale production. By blending comprehensive modeling, experimental validation, and custom equipment design, we prioritize performance optimization, yield improvement, and overall uncertainty reduction."

Since its inception in 1974, ABEC has dedicated itself to delivering engineered solutions and services to the global biotech sector. Today, most of the leading pharmaceutical and biotech firms rely on ABEC for their innovative equipment and processes, trust that has fostered a strong reputation within the industry. ABEC’s wealth of experience, complete in-house capabilities, and flexible, customized approach serve to limit costs and time to market while maximizing productivity.

With this expansion of the Process Sciences group, ABEC reinforces its resolve to lead and innovate within the biopharma space, positioning itself as a crucial ally to manufacturers undergoing the rigorous phases of drug development and production.